CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis
TSX:CHR - Toronto Stock Exchange - CA17040T8885 - Common Stock - Currency: CAD
Taking everything into account, CHR scores 5 out of 10 in our fundamental rating. CHR was compared to 8 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on CHR. These ratings could make CHR a good candidate for value investing.
1. Profitability
1.1 Basic Checks
CHR had positive earnings in the past year.
In the past year CHR had a positive cash flow from operations.
In multiple years CHR reported negative net income over the last 5 years.
Each year in the past 5 years CHR had a positive operating cash flow.
1.2 Ratios
CHR's Return On Assets of -17.42% is on the low side compared to the rest of the industry. CHR is outperformed by 62.50% of its industry peers.
CHR has a Return On Equity (-47.80%) which is comparable to the rest of the industry.
CHR has a better Return On Invested Capital (6.29%) than 100.00% of its industry peers.
CHR had an Average Return On Invested Capital over the past 3 years of 5.30%. This is in line with the industry average of 5.84%.
The last Return On Invested Capital (6.29%) for CHR is above the 3 year average (5.30%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.42% | ||
| ROE | -47.8% | ||
| ROIC | 6.29% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
1.3 Margins
Looking at the Operating Margin, with a value of 6.77%, CHR is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
In the last couple of years the Operating Margin of CHR has declined.
CHR's Gross Margin of 65.04% is amongst the best of the industry. CHR outperforms 100.00% of its industry peers.
CHR's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.77% | ||
| PM (TTM) | N/A | ||
| GM | 65.04% |
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHR is destroying value.
CHR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CHR has been increased compared to 5 years ago.
Compared to 1 year ago, CHR has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.84, we must say that CHR is in the distress zone and has some risk of bankruptcy.
CHR has a worse Altman-Z score (0.84) than 62.50% of its industry peers.
CHR has a debt to FCF ratio of 3.86. This is a good value and a sign of high solvency as CHR would need 3.86 years to pay back of all of its debts.
The Debt to FCF ratio of CHR (3.86) is better than 100.00% of its industry peers.
CHR has a Debt/Equity ratio of 0.68. This is a neutral value indicating CHR is somewhat dependend on debt financing.
CHR's Debt to Equity ratio of 0.68 is amongst the best of the industry. CHR outperforms 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | 3.86 | ||
| Altman-Z | 0.84 |
ROIC/WACC0.76
WACC8.25%
2.3 Liquidity
A Current Ratio of 1.22 indicates that CHR should not have too much problems paying its short term obligations.
CHR's Current ratio of 1.22 is fine compared to the rest of the industry. CHR outperforms 62.50% of its industry peers.
A Quick Ratio of 0.71 indicates that CHR may have some problems paying its short term obligations.
With a Quick ratio value of 0.71, CHR perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
CHR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.14%.
The earnings per share for CHR have been decreasing by -19.03% on average. This is quite bad
The Revenue for CHR has decreased by -14.15% in the past year. This is quite bad
Measured over the past years, CHR shows a small growth in Revenue. The Revenue has been growing by 0.56% on average per year.
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%
3.2 Future
Based on estimates for the next years, CHR will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.82% on average per year.
Based on estimates for the next years, CHR will show a small growth in Revenue. The Revenue will grow by 0.78% on average per year.
EPS Next Y62.27%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
EPS Next 5YN/A
Revenue Next Year-2.29%
Revenue Next 2Y-2.03%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 12.44, the valuation of CHR can be described as correct.
Based on the Price/Earnings ratio, CHR is valued cheaper than 87.50% of the companies in the same industry.
CHR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.32.
Based on the Price/Forward Earnings ratio of 10.11, the valuation of CHR can be described as reasonable.
Based on the Price/Forward Earnings ratio, CHR is valued cheaper than 87.50% of the companies in the same industry.
CHR is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.44 | ||
| Fwd PE | 10.11 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CHR is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CHR is valued cheaper than 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.04 | ||
| EV/EBITDA | 4.85 |
4.3 Compensation for Growth
CHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y16.29%
EPS Next 3Y8.82%
5. Dividend
5.1 Amount
CHR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:CHR (6/17/2025, 7:00:00 PM)
20.65
-0.43 (-2.04%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)
Earnings (Next)
Inst Owners2.5%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap546.40M
Analysts78.18
Price Target28.23 (36.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-7.29%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.69%
Min EPS beat(2)3.87%
Max EPS beat(2)25.51%
EPS beat(4)3
Avg EPS beat(4)39.29%
Min EPS beat(4)-80.2%
Max EPS beat(4)207.96%
EPS beat(8)4
Avg EPS beat(8)7.83%
EPS beat(12)5
Avg EPS beat(12)1.78%
EPS beat(16)7
Avg EPS beat(16)0.15%
Revenue beat(2)0
Avg Revenue beat(2)-3.86%
Min Revenue beat(2)-3.95%
Max Revenue beat(2)-3.78%
Revenue beat(4)0
Avg Revenue beat(4)-6.49%
Min Revenue beat(4)-10.27%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-1.85%
Revenue beat(12)5
Avg Revenue beat(12)-1.08%
Revenue beat(16)9
Avg Revenue beat(16)6.44%
PT rev (1m)3.2%
PT rev (3m)0.41%
EPS NQ rev (1m)4.53%
EPS NQ rev (3m)718.22%
EPS NY rev (1m)6.33%
EPS NY rev (3m)13.9%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)0.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.44 | ||
| Fwd PE | 10.11 | ||
| P/S | 0.39 | ||
| P/FCF | 5.04 | ||
| P/OCF | 3.66 | ||
| P/B | 1.06 | ||
| P/tB | 1.08 | ||
| EV/EBITDA | 4.85 |
EPS(TTM)1.66
EY8.04%
EPS(NY)2.04
Fwd EY9.89%
FCF(TTM)4.1
FCFY19.86%
OCF(TTM)5.65
OCFY27.35%
SpS52.7
BVpS19.51
TBVpS19.18
PEG (NY)0.2
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.42% | ||
| ROE | -47.8% | ||
| ROCE | 8.48% | ||
| ROIC | 6.29% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 6.8% | ||
| OM | 6.77% | ||
| PM (TTM) | N/A | ||
| GM | 65.04% | ||
| FCFM | 7.78% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | 3.86 | ||
| Debt/EBITDA | 1.9 | ||
| Cap/Depr | 45.9% | ||
| Cap/Sales | 2.93% | ||
| Interest Coverage | 1.46 | ||
| Cash Conversion | 81.41% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 0.84 |
F-Score6
WACC8.25%
ROIC/WACC0.76
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
EPS Next Y62.27%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%
Revenue Next Year-2.29%
Revenue Next 2Y-2.03%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
EBIT growth 1Y-59.15%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year88.24%
EBIT Next 3Y15.21%
EBIT Next 5YN/A
FCF growth 1Y-55.84%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-51.04%
OCF growth 3Y12.73%
OCF growth 5Y0.25%